W Slikker

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Biologically-based dose-response model for neurotoxicity risk assessment
    W Slikker
    Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, AR 72079 9502, USA
    Toxicol Lett 102:429-33. 1998
  2. ncbi Behavioral test methods workshop
    William Slikker
    National Center for Toxicological Research FDA, Division of Neurotoxicology, 3900 NCTR Rd Jefferson 72079, United States
    Neurotoxicol Teratol 27:417-27. 2005
  3. ncbi A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools
    Zengjun Xu
    Division of Neurotoxicology, National Center for Toxicological Research, U S Food and Drug Administration, 3900 NCTR Road, Jefferson, Arkansas 72079, USA
    BMC Bioinformatics 6:S8. 2005
  4. ncbi Systems biology/systems toxicology: application to developmental neurotoxicology/neuroprotection
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 1053:309-10. 2005
  5. ncbi Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine
    William Slikker
    Division of Neurotoxicology, NCTR FDA, Jefferson, Arkansas 72079, USA
    Crit Rev Toxicol 35:703-11. 2005
  6. ncbi Improving predictive modeling in pediatric drug development: pharmacokinetics, pharmacodynamics, and mechanistic modeling
    William Slikker
    Office of Research, National Center for Toxicological Research FDA, 3900 NCTR Road, Jefferson, Arkansas 72079 9502, USA
    Ann N Y Acad Sci 1053:505-18. 2005
  7. ncbi Gender-based differences in rats after chronic dietary exposure to genistein
    W Slikker
    Division of Neurotoxicology, National Center for Toxicological Research Food and Drug Administration, Jefferson, Arkansas 72079 9502, USA
    Int J Toxicol 20:175-9. 2001
  8. ncbi Biomarkers of adult and developmental neurotoxicity
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research FDA, HFT 132, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Toxicol Appl Pharmacol 206:255-60. 2005
  9. ncbi Application of a systems biology approach to developmental neurotoxicology
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Reprod Toxicol 19:305-19. 2005
  10. ncbi Neuroimaging: strategies to illuminate environment-disease linkages. Session II. Summary and research needs
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, AR 72079, USA
    Neurotoxicology 25:501-2. 2004

Collaborators

Detail Information

Publications76

  1. ncbi Biologically-based dose-response model for neurotoxicity risk assessment
    W Slikker
    Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, AR 72079 9502, USA
    Toxicol Lett 102:429-33. 1998
    ..This quantitative approach uses all the available data, takes into account the variability of the data and provides an actual risk at a given dose of domoic acid...
  2. ncbi Behavioral test methods workshop
    William Slikker
    National Center for Toxicological Research FDA, Division of Neurotoxicology, 3900 NCTR Rd Jefferson 72079, United States
    Neurotoxicol Teratol 27:417-27. 2005
    ....
  3. ncbi A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools
    Zengjun Xu
    Division of Neurotoxicology, National Center for Toxicological Research, U S Food and Drug Administration, 3900 NCTR Road, Jefferson, Arkansas 72079, USA
    BMC Bioinformatics 6:S8. 2005
    ..MPP+ depletes dopamine content and elicits cell death in PC12 cells. However, the mechanism of MPP+-induced neurotoxicity is still unclear...
  4. ncbi Systems biology/systems toxicology: application to developmental neurotoxicology/neuroprotection
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 1053:309-10. 2005
  5. ncbi Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine
    William Slikker
    Division of Neurotoxicology, NCTR FDA, Jefferson, Arkansas 72079, USA
    Crit Rev Toxicol 35:703-11. 2005
    ..As data become available with the advent of the use of the nicotine patch in pregnant humans, the question as to the relative importance of smoking per se versus nicotine alone may be determined...
  6. ncbi Improving predictive modeling in pediatric drug development: pharmacokinetics, pharmacodynamics, and mechanistic modeling
    William Slikker
    Office of Research, National Center for Toxicological Research FDA, 3900 NCTR Road, Jefferson, Arkansas 72079 9502, USA
    Ann N Y Acad Sci 1053:505-18. 2005
    ..Issues addressed in this workshop should be considered in the development of new predictive and mechanistic models of drug kinetics and dynamics in the developing human...
  7. ncbi Gender-based differences in rats after chronic dietary exposure to genistein
    W Slikker
    Division of Neurotoxicology, National Center for Toxicological Research Food and Drug Administration, Jefferson, Arkansas 72079 9502, USA
    Int J Toxicol 20:175-9. 2001
    ..Additional studies, perhaps in nonhuman primates, are necessary to further predict the effect(s) of genistein on human gender-based development...
  8. ncbi Biomarkers of adult and developmental neurotoxicity
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research FDA, HFT 132, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Toxicol Appl Pharmacol 206:255-60. 2005
    ....
  9. ncbi Application of a systems biology approach to developmental neurotoxicology
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Reprod Toxicol 19:305-19. 2005
    ....
  10. ncbi Neuroimaging: strategies to illuminate environment-disease linkages. Session II. Summary and research needs
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, AR 72079, USA
    Neurotoxicology 25:501-2. 2004
  11. ncbi Chronic marijuana smoke exposure in the rhesus monkey. IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats
    S F Ali
    Division of Reproductive and Developmental Toxicology, National Center for Toxicological Research, Jefferson, AR 72079
    Pharmacol Biochem Behav 40:677-82. 1991
    ..In the monkey brain, we found no alterations in the concentration of neurotransmitters in caudate nucleus, frontal cortex, hypothalamus or brain stem.(ABSTRACT TRUNCATED AT 250 WORDS)..
  12. ncbi Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts
    S Z Imam
    Neurochemistry Laboratory Division of Neurotoxicology, HFT-132, National Center for Toxicological Research/FDA, 3900 NCTR Rd, Jefferson, AR 72079, USA
    Ann N Y Acad Sci 939:366-80. 2001
    ..These antioxidants and decomposition catalysts may have therapeutic potential in the treatment of psychostimulant addictions...
  13. ncbi The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex
    X Zou
    Division of Neurotoxicology, National Center for Toxicological Research, HFT 132, U S Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA
    Neuroscience 151:1053-65. 2008
    ....
  14. ncbi Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia
    F Liu
    Division of Neurotoxicology, National Center for Toxicological Research U S Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Int J Dev Neurosci 29:351-8. 2011
    ..The changes in schizophrenia-relevant genes after repeated PCP exposure during development may provide important information concerning the validation of an animal model for this disorder...
  15. ncbi L-carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture
    C Wang
    Division of Neurotoxicology, HFT 132, National Center for Toxicological Research U S Food and Drug Administration, Jefferson, AR 72079, USA
    Neuroscience 144:46-55. 2007
    ..L-carnitine blocked these effects of MPP+ suggesting its potential therapeutic utility in degenerative disorders such as Parkinson's disease, Alzheimer's disease, ornithine transcarbamylase deficiency and other mitochondrial diseases...
  16. ncbi Formation of artifactual metabolites of doxylamine following acid hydrolysis
    C L Holder
    Department of Health and Human Services, Food and Drug Administration, Jefferson, AR 72079
    J Chromatogr 419:113-22. 1987
    ..These artifactual products were shown to originate from the acid hydrolysis of 2-[1-phenyl-1-(2-pyridinyl)ethoxy] acetic acid and not from doxylamine...
  17. ncbi Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain
    Z Binienda
    Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, AR 72079, USA
    Neurosci Lett 251:173-6. 1998
    ..The depletion of GSH and induction of antioxidant enzyme activities after the 3-NPA exposure suggest conditions favorable for oxidative stress...
  18. ncbi An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate
    J F Bowyer
    Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079, USA
    Toxicol Sci 55:133-42. 2000
    ....
  19. ncbi Gene expression profiling in the developing rat brain exposed to ketamine
    Q Shi
    Division of Systems Toxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA
    Neuroscience 166:852-63. 2010
    ....
  20. ncbi The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey
    P Morris
    Division of Neurotoxicology, Food and Drug Administration, Jefferson, AR 72079, USA
    Neurotoxicol Teratol 19:47-57. 1997
    ..It was concluded that, in a rhesus monkey model, chronic cocaine exposure throughout pregnancy had no significant effect on maternal outcome, but did significantly affect infant outcome as assessed in this investigation...
  21. ncbi Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys
    M G Paule
    Division of Neurotoxicology, National Center for Toxicological Research FDA, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Neurotoxicol Teratol 33:220-30. 2011
    ..Supported by NICHD, CDER/FDA and NCTR/FDA...
  22. ncbi Metabolism of doxylamine succinate in Fischer 344 rats. Part III: Conjugated urinary and fecal metabolites
    C L Holder
    Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas 72079
    J Anal Toxicol 14:247-51. 1990
    ..The conjugated doxylamine metabolites that were isolated, quantitated, and identified are doxylamine O-glucuronide, N-desmethyl-doxylamine O-glucuronide, and N,N-didesmethyldoxylamine O-glucuronide...
  23. ncbi Gestational exposure to phencyclidine (PCP) in rats decreases PCP binding sites in term fetal brain
    S F Ali
    Division of Reproductive and Developmental Toxicology, National Center for Toxicological Research, Jefferson, AR 72079
    Int J Dev Neurosci 6:547-52. 1988
    ..These data indicate that gestational exposure to PCP decreases high affinity binding of PCP in term fetal brain at doses which do not alter maternal PCP receptor binding...
  24. ncbi MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH
    X Zhang
    Division of Neurotoxicology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    J Neural Transm 118:203-11. 2011
    ..This study demonstrates that microPET imaging is capable of distinguishing differences in retention of [(18)F]-DFNSH in ROI and suggests that this compound may serve as a minimally invasive biomarker of neuronal apoptosis in rodents...
  25. ncbi Distribution of 2,4-dichlorophenoxyacetic acid (2,4-D) in maternal and fetal rabbits
    J A Sandberg
    Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, Arkansas 72079, USA
    J Toxicol Environ Health 49:497-509. 1996
    ..However, its development may not be complete due to the higher brain tissue to plasma ratios in the fetus compared to the dam...
  26. ncbi Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells
    Z Xu
    Neurochemistry Laboratory, Division of Neurotoxicology, HFT-132, National Center for Toxicological Research, Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA
    Neurotoxicology 26:729-37. 2005
    ..The data indicates that selective transcription factors are involved in MPP(+)-induced neurotoxicity and it provides mechanistic information that may be applicable to animal studies with MPTP and clinical studies of Parkinson's disease...
  27. ncbi Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain
    S F Ali
    Division of Reproductive and Developmental Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079
    Neurotoxicology 10:383-92. 1989
    ..These data demonstrated that maternal PCP exposure resulted in prolonged exposure of the developing CNS and also indicated that gestational exposure to PCP decreased high affinity binding sites of PCP in term fetal brain...
  28. ncbi Pharmacokinetics of doxylamine, a component of Bendectin, in the rhesus monkey
    W Slikker
    Division of Reproductive and Developmental Toxicology, National Center for Toxicological Research, Jefferson, AR 72079
    Reprod Toxicol 3:187-96. 1989
    ....
  29. ncbi Application of electrophysiological method to study interactions between ibogaine and cocaine
    Z Binienda
    Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 914:387-93. 2000
    ..DA turnover increased significantly after IBO alone but was not observed after IBO/COC treatment. The alterations in ECoG and neurotransmitter levels suggest a decreased response to COC following IBO pretreatment...
  30. ncbi Plasma elimination and urinary excretion of methapyrilene in the rat
    D W Kelly
    National Center for Toxicological Research, University of Arkansas for Medical Sciences, Jefferson, AR 72079 9502
    Drug Metab Dispos 18:1018-24. 1990
    ..The terminal plasma elimination t1/2 of methapyrilene did not increase with increasing doses (2.75 hr, 0.7 mg/kg; 2.81 hr, 3.5 mg/kg); thus, methapyrilene does not exhibit dose-dependent elimination over this 5-fold dose range...
  31. ncbi Fast-atom bombardment and thermospray mass spectrometry for the characterization of two glucuronide metabolites of methapyrilene
    J O Lay
    Food and Drug Administration, National Center for Toxicological Research, Jefferson, Arkansas 72079
    Rapid Commun Mass Spectrom 3:72-5. 1989
    ..While loss of the sugar moiety indicated a glucuronide, additional fragmentation confirmed the presence of the underlying ethylenediamine substructure which is characteristic of this class of antihistamines...
  32. ncbi Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment
    D L Frederick
    Division of Neurotoxicology, National Center for Toxicological Research, Jefferson Arkansas 72079, USA
    Ann N Y Acad Sci 844:183-90. 1998
    ..e., significant decreases of ca. 50% in serotonin in frontal cortex and hippocampus) were observed in all monkeys approximately six months after short-course, high-dose MDMA or d-FEN treatment...
  33. ncbi Temporal development of 2',3'-dideoxyinosine (ddI)-induced peripheral myelinopathy
    T A Patterson
    Division of Neurotoxicology, National Center for Toxicological Research FDA, 72079 9502, Jefferson, AR, USA
    Neurotoxicol Teratol 22:429-34. 2000
    ..Although abnormal morphology was present at 20 weeks of dosing, the effect was not as robust as at 15 weeks. This suggests that the nerve may partially recover from the effects of ddI with time. Published by Elsevier Science Inc...
  34. ncbi Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice
    S Z Imam
    Neurochemistry Laboratory, Division of Neurotoxicology, HFT-132, National Center for Toxicological Research/FDA, 3900 NCTR Rd, Jefferson, AR 72079-9502, USA
    Brain Res Mol Brain Res 91:174-8. 2001
    ..These data suggest that METH might cause its neurotoxic effects via the production of free radicals and secondary perturbations in the expression of genes known to be involved in apoptosis and cell death machinery...
  35. ncbi Embryo-maternal distribution of basic compounds in the CD-1 mouse: doxylamine and nicotine
    L G Roberts
    Division of Reproductive and Developmental Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079
    Toxicol Appl Pharmacol 97:134-40. 1989
    ..Our results indicate that the partitioning of these basic compounds between the maternal plasma and the early postimplantation rodent embryo is not a consequence of the pH gradient between the two compartments alone...
  36. ncbi Transplacental pharmacokinetics and fetal distribution of 2', 3'-didehydro-3'-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques
    T A Patterson
    Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, Arkansas 72079 9502, USA
    Teratology 62:93-9. 2000
    ....
  37. ncbi Black-gold: a simple, high-resolution histochemical label for normal and pathological myelin in brain tissue sections
    L Schmued
    Division of Neurotoxicology, National Center for Toxicological Research FDA, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Brain Res 837:289-97. 1999
    ..Advantages associated with the Black-Gold technique include high resolution, high contrast, short histochemical processing time, and consistent reproducibility...
  38. ncbi Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells
    W Slikker
    Division of Neurotoxicology, National Center for Toxicological Research/US FDA, 3900 NCTR Drive, Jefferson, AR 72079, USA
    Free Radic Biol Med 31:405-11. 2001
    ....
  39. ncbi Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine
    F C Pereira
    Neurochemistry Laboratory, Division of Neurotoxicology, NCTR, Jefferson 72079, AR, USA
    J Neural Transm 109:1151-8. 2002
    ..A single dose of METH-induced an increase in DA turnover [(DOPAC + HVA)/DA] concomitant with an acute DA release followed by transient DA and DOPAC depletion in the rat CN...
  40. ncbi Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase
    S Z Imam
    Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research FDA, Jefferson, Arkansas, USA
    J Neurochem 76:745-9. 2001
    ..The dopaminergic damage induced by METH treatment was also attenuated in nNOS-/- or SOD-Tg mice. These data further confirm that METH causes its neurotoxic effects via the production of peroxynitrite...
  41. ncbi Effect of manganese on the concentration of amino acids in different regions of the rat brain
    G W Lipe
    Neurochemistry Laboratory, FDA, Jefferson, AR 72079, USA
    J Environ Sci Health B 34:119-32. 1999
    ..These data suggest that chronic Mn exposure can produce a decrease in body weight gain in adult rats and alterations in amino acids in different regions of weanling and adult rat brains...
  42. ncbi The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture
    C Wang
    Division of Neurotoxicology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079 0502, USA
    Neuroscience 132:967-77. 2005
    ..These data suggest that NR1 antisense offers neuroprotection from apoptosis in vitro, and that upregulation of the NR1 following ketamine administration is, at least, partially responsible for the observed apoptosis...
  43. ncbi Metabolism of methapyrilene by Fischer-344 rat and B6C3F1 mouse hepatocytes
    D W Kelly
    National Center for Toxicological Research, Jefferson, Arkansas 72079 9502
    Xenobiotica 22:1367-81. 1992
    ....
  44. ncbi Selective alterations of gene expression in mice induced by MPTP
    Z Xu
    Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas 72079, USA
    Synapse 55:45-51. 2005
    ..Future studies will focus on gene expression of other pathways that may be affected by MPTP treatment and investigation of gene expression in specific cell types in vivo using LCM technology...
  45. ncbi Prediction of organophosphorus acetylcholinesterase inhibition using three-dimensional quantitative structure-activity relationship (3D-QSAR) methods
    J El Yazal
    Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, Arkansas 72079, USA
    Toxicol Sci 63:223-32. 2001
    ..Also, the pharmacophores offer an additional means of designing AChE inhibitors as potential therapeutic agents for central nervous system diseases...
  46. ncbi Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons
    A C Scallet
    Division of Neurotoxicology, NCTR FDA, Jefferson, Arkansas 72079, USA
    Toxicol Sci 81:364-70. 2004
    ....
  47. ncbi The role of caspase III inhibition in methamphetamine-induced alterations in p53 and bcl-2 expression: correlation with dopaminergic neurotoxicity
    Syed Z Imam
    Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 993:350; discussion 387-93. 2003
  48. ncbi Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity
    Kathleen A Haberny
    Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA
    Toxicol Sci 68:9-17. 2002
    ....
  49. ncbi Adaptation to repeated cocaine administration in rats
    Zbigniew K Binienda
    Division of Neurotoxicology, NCTR FDA, Jefferson, Arkansas 72029, USA
    Ann N Y Acad Sci 965:172-9. 2002
    ..Further studies are necessary to establish whether regional alterations in blood flow and metabolic activity may underlie such observations...
  50. ncbi Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture
    Cheng Wang
    Division of Neurotoxicology, National Center for Toxicological Research Food and Drug Administration, Jefferson, Arkansas 72079 0502, USA
    Toxicol Sci 91:192-201. 2006
    ..Ketamine-induced effects were blocked by NR1 antisenses and SN-50. These data suggest that NR1 antisenses and SN-50 offer neuroprotection from the enhanced degeneration induced by ketamine in vitro...
  51. ncbi Systems biology approaches for toxicology
    William Slikker
    National Center for Toxicological Research, U S Food and Drug Administration, Jefferson, Arkansas 72079 9502, USA
    J Appl Toxicol 27:201-17. 2007
    ..Published in 2007 John Wiley & Sons, Ltd...
  52. ncbi Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system
    Cheng Wang
    Division of Neurotoxicology, National Center for Toxicological Research F3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Anesth Analg 106:1643-58. 2008
    ..Our focus on ketamine should not be construed as implying that the risk of neurodegeneration with ketamine is greater, or less, than with other anesthetics. We are simply describing the effects where we have the most preclinical data...
  53. ncbi Sex differences in cytochrome P450 1B1, an estrogen-metabolizing enzyme, in the rhesus monkey telencephalon
    Andrew C Scallet
    Division of Neurotoxicology, National Center for Toxicological Research, NCTR FDA, 3900 NCTR Drive, Jefferson, AR 72079, USA
    J Chem Neuroanat 29:71-80. 2005
    ..These results suggest that CYP1B1 may subserve widespread metabolic functions in the female primate brain but have more restricted actions within the hippocampal pyramidal neurons of the male...
  54. ncbi The differential JunB responses to inhibition of succinate dehydrogenase in rat hippocampus and liver
    Beata D Przybyla-Zawislak
    Division of Neurotoxicology, FDA National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Neurosci Lett 381:354-7. 2005
    ..In conclusion, out of the three ITFs transcripts examined here junb may activate different pathways depending on the tissue as indicated by differential responses to mitochondrial inhibition in the hippocampus and liver...
  55. ncbi Incorporating children's toxicokinetics into a risk framework
    Gary Ginsberg
    Connecticut Department of Public Health, Hartford, Connecticut 06134, USA
    Environ Health Perspect 112:272-83. 2004
    ..This type of resource information is intended to help the assessor begin to address the issues raised in this paper...
  56. ncbi Neuroimaging: new approaches for neurotoxicology
    Amy Pogge
    Division of Neurotoxicology, National Center for Toxicology Research, 3900 NCTR Road, Jefferson, AR 72079 9502, USA
    Neurotoxicology 25:525-31. 2004
    ..In addition, as these technologies have been primarily developed for clinical purposes, they provide an outstanding opportunity for cross-species and animal-to-human extrapolation and testing...
  57. ncbi Sex-selective hippocampal alterations after adolescent nicotine administration: effects on neurospecific proteins
    Zengjun Xu
    Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Nicotine Tob Res 5:955-60. 2003
    ..We conclude that administration of nicotine to adolescent rats alters neuroproteins in the female hippocampus during withdrawal, effects that could contribute to neurobehavioral deficits...
  58. ncbi Neurobehavioral assessment: a survey of use and value in safety assessment studies
    Lawrence D Middaugh
    Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Toxicol Sci 76:250-61. 2003
    ..The survey results emphasize the need for further research into the methods of behavioral assessment as well as the mechanisms underlying the neurobehavioral alterations...
  59. ncbi Neuroprotection or neurotoxicity: impact of discontinuous dose-response curves on risk assessment
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 993:158; discussion 159-60. 2003
  60. ncbi Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations
    John F Bowyer
    Division of Neurotoxicology and Biometry and Risk Assessment, National Center for Toxicological Research FDA, 72079 9502, Jefferson, AR, USA
    Neurotoxicology 24:379-90. 2003
    ..There were 80% reductions in the plasma membrane-associated 5-HT transporters 6 months after either the FEN or MDMA dosing regimen indicating that both treatments produced long-term serotonergic effects...
  61. ncbi Role of the standard deviation in the estimation of benchmark doses with continuous data
    David W Gaylor
    Gaylor and Associates, LLC, Little Rock, AR, USA
    Risk Anal 24:1683-7. 2004
    ..The bias increases as s(m) increases relative to s(a). The bias is relatively small if s(m) is less than one-third of s(a), a condition achieved in most experimental designs...
  62. ncbi Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study
    Bobby Gough
    Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 965:410-20. 2002
    ..5 or 5 mg/kg. All dose levels of PMA significantly decreased 5-HIAA (50 to 70%). These data suggest that PMA, like MDMA and METH, is capable of producing dopaminergic and serotonergic neurotoxicity...
  63. ncbi Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture
    Cheng Wang
    Division of Neurotoxicology, National Center for Toxicological Research US Food and Drug Administration, HFT 132 Jefferson, AR, USA
    Neurotoxicology 29:613-20. 2008
    ..These data indicate a role for nitric oxide in the enhanced degeneration induced by ketamine in vitro and also suggest that blocking neuronal nitric oxide synthase (nNOS) may help reduce the risk of ketamine in pediatrics...
  64. ncbi Flow cytometric analysis of micronuclei in peripheral blood reticulocytes IV: an index of chromosomal damage in the rhesus monkey (Macaca mulatta)
    Charlotte E Hotchkiss
    The Bionetics Corporation, Jefferson, Arkansas 72079, USA
    Toxicol Sci 102:352-8. 2008
    ..Microscopy-based scoring is challenging due to the low frequency of RETs and MN-RET in monkeys, but sufficient numbers of cells are easily scored with the flow cytometric procedure...
  65. ncbi Methylphenidate and chromosome damage
    David Jacobson-Kram
    Cancer Lett 260:216-8. 2008
  66. ncbi Application of proteomics to the study of molecular mechanisms in neurotoxicology
    Richard M LoPachin
    Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, Moses 7, 111 E, 210th St, Bronx, NY 10467, USA
    Neurotoxicology 24:761-75. 2003
    ....
  67. ncbi Postnatal growth considerations for PBPK modeling
    Richard H Luecke
    Department of Chemical Engineering, University of Missouri Columbia, Columbia, Missouri, USA
    J Toxicol Environ Health A 70:1027-37. 2007
    ..Upper limits of body weight were chosen that reflect the available data used to define the algorithms; above these limits a set percent body weight was assigned to all organs/tissues...
  68. ncbi Regional societies: fostering competitive research through virtual infrastructures
    Steven F Jennings
    Department of Applied Science at the University of Arkansas at Little Rock, USA
    PLoS Biol 2:e372. 2004
  69. ncbi Methamphetamine-induced dopaminergic neurotoxicity and production of peroxynitrite are potentiated in nerve growth factor differentiated pheochromocytoma 12 cells
    Syed Z Imam
    Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Resarch/US FDA, Jefferson, Arkansas 72079, USA
    Ann N Y Acad Sci 965:204-13. 2002
    ..The current study supports the hypothesis that METH acts at the dopaminergic nerve terminals and produces dopaminergic damage by the production of free radical peroxynitrite...
  70. ncbi Dose-dependent transitions in mechanisms of toxicity
    William Slikker
    US FDA National Center for Toxicological Research, Jefferson, AR 72079, USA
    Toxicol Appl Pharmacol 201:203-25. 2004
    ..This paper addresses the issues discussed at both workshops, and presents the consensus conclusions drawn by expert participants...
  71. ncbi Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data
    Jennifer Seed
    US Environmental Protection Agency, Washington, DC, USA
    Crit Rev Toxicol 35:664-72. 2005
    ....
  72. ncbi Concern over decreased training in embryology and developmental/reproductive toxicology
    Gary Kimmel
    Birth Defects Res B Dev Reprod Toxicol 71:191-2. 2004
  73. ncbi Maternal smoking during pregnancy and childhood obesity
    Rudiger Von Kries
    Institute of Social Pediatrics and Adolescent Medicine, Ludwig Maximilian University of Munich, Munich, Germany
    Am J Epidemiol 156:954-61. 2002
    ....
  74. ncbi Ketamine-induced neuronal cell death in the perinatal rhesus monkey
    William Slikker
    Division of Neurotoxicology, National Center for Toxicological Research, U S Food and Drug Administration, Jefferson, AR 72079 0502, USA
    Toxicol Sci 98:145-58. 2007
    ..However, a shorter duration of ketamine anesthesia (3 h) did not result in neuronal cell death in the 5-day-old monkey...
  75. ncbi Effect of prolonged ketamine exposure on cardiovascular physiology in pregnant and infant rhesus monkeys (Macaca mulatta)
    Charlotte E Hotchkiss
    The Bionetics Corporation, National Center for Toxicological Research FDA, Jefferson, AR, USA
    J Am Assoc Lab Anim Sci 46:21-8. 2007
    ..Investigators should consider these effects when designing experiments and evaluating experimental outcomes in monkeys...